Insulet Stock Drops Amid User Growth Concerns
Insulet's stock fell 8.8% despite raised revenue guidance, amid concerns over slowing user growth.
- Latest
- Trending
Insulet's stock fell 8.8% despite raised revenue guidance, amid concerns over slowing user growth.
Starbucks shares climb 2.7% as activist Starboard invests. Stake size unknown, follows Elliot's recent involvement.
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Nvidia sees a 2% weekly loss despite strong AI demand, as analysts view this as a buying opportunity.
Sweetgreen soars on strong earnings, while Intel drops. Akamai leads the S&P 500 on robust demand.
Array Technologies lowers 2024 guidance due to project delays but remains optimistic about long-term solar industry growth.
Cisco stock drops as company announces thousands more layoffs amid strategic focus shift to AI and cybersecurity.
Purple Innovation sees sales increase, revises revenue outlook downwards, highlights profitability improvements and cost management.
10x Genomics sees 4% revenue growth in Q2 2024 but lowers full-year outlook due to economic headwinds affecting instrument sales.
Explore Dogecoin, AAVE, and DTX's unique growth potential amid crypto market shifts.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.